Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | TTR | P02766 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | CRHBP | P24387 | 1/20 | 0.40 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.38 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | ALB | P02768 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4782428 | 0.88 | ESR1 (0.35) | TSHRCYP3A4TDP1HIF1AHSD17B10 | |
| SCHEMBL8376286 | 0.86 | HSD17B10 (0.42) | TSHRCYP3A4TDP1HIF1AHSD17B10 | |
| SCHEMBL4603027 | 0.85 | GABRA1 (0.47) | TSHRCYP3A4HIF1AHPGDCYP2C19 | |
| SCHEMBL6553806 | 0.83 | TSHR (0.41) | TSHRCYP3A4TDP1HIF1AHSD17B10 | |
| SCHEMBL1596341 | 0.81 | TSHR (0.48) | TSHRCYP3A4TDP1HIF1AHSD17B10 | |
| SCHEMBL1596252 | 0.81 | TSHR (0.48) | TSHRCYP3A4TDP1HIF1AHSD17B10 | |
| SCHEMBL4799655 | 0.80 | CRHBP (0.46) | TSHRCYP3A4TDP1ALDH1A1CRHBP | |
| SCHEMBL13920802 | 0.80 | ALDH1A1 (0.44) | TSHRCYP3A4TDP1HIF1AHSD17B10 | |
| SCHEMBL234097 | 0.79 | ALDH1A1 (0.36) | TSHRCYP3A4TDP1HIF1AALDH1A1 | |
| SCHEMBL1595906 | 0.77 | TSHR (0.44) | TSHRCYP3A4TDP1HIF1AHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 270 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105899577-B | Copolycarbonate and composition comprising the Copolycarbonate | LG化学株式会社 | 2019-08-16 | — | — | CN | claimed |
| CN-109563336-A | Polycarbonate compositions and articles comprising the same | 株式会社LG化学 | 2019-04-02 | — | — | CN | claimed |
| CN-107108876-B | Copolycarbonate and composition containing same | 株式会社LG化学 | 2019-03-08 | — | — | CN | claimed |
| CN-105899607-B | Poly carbonate resin composition | LG化学株式会社 | 2018-11-16 | — | — | CN | claimed |
| CN-106715527-B | Copolycarbonate resin and method for producing same | 株式会社LG化学 | 2018-11-13 | — | — | CN | claimed |
| CN-105899575-B | Copolycarbonate and composition containing same | LG化学株式会社 | 2018-07-24 | — | — | CN | claimed |
| CN-105899573-B | Copolycarbonate and composition comprising the Copolycarbonate | LG化学株式会社 | 2018-07-13 | — | — | CN | claimed |
| EP-0694035-B1 | WATER-SOLUBLE CAMPTOTHECIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS | PHARMACIA ITALIA SPA (IT) | 2002-07-17 | — | — | EP | claimed |
| US-5595789-A | CROSSLINKAKLE RESIN COATING ON SUBSTRATES FOR IMPACT STRENGTH, HEAT DEFLECTION AND DIMENSIONAL STABILITY | BAYER AG (DE) | 1997-01-21 | — | — | US | claimed |
| EP-0187640-B1 | FLAME RETARDANT POLYCARBONATE COMPOSITIONS | GENERAL ELECTRIC COMPANY (US) | 1989-10-18 | — | — | EP | claimed |
| US-4751260-A | HALOGEN-CONTAINING POLYCARBONATES, STYRENE-(METH)-ACRYLONITRILE COPOLYMERS, TETRAFLUOROETHYLENE POLYMERS, PHOSPHORUS COMPOUNDS | BAYER AKTIENGESELLSCHAFT (DE) | 1988-06-14 | — | — | US | claimed |
| US-4731405-A | Thermoplastic moulding materials with high tracking resistance | BAYER AKTIENGESELLSCHAFT (DE) | 1988-03-15 | — | — | US | claimed |
| EP-0187640-A1 | Flame retardant polycarbonate compositions | GENERAL ELECTRIC COMPANY (US) | 1986-07-16 | — | — | EP | claimed |
| US-4579896-A | CONTAINING BIS CYCLI CARBONATE AND EITHER SULFONIC ACID SALT DERIVATIVES OR HALOGEN-CONTAINING COMPOUNDS | GENERAL ELECTRIC COMPANY (US) | 1986-04-01 | — | — | US | claimed |
| US-12617753-B2 | Urea derivatives and their use as curatives and curative accelerators for resin systems | HEXCEL COMPOSITES LIMITED (GB) | 2026-05-05 | — | — | US | disclosed |
| EP-3959217-B1 | IMPROVEMENTS IN OR RELATING TO CURATIVES | HEXCEL COMPOSITES LTD (GB) | 2025-10-15 | — | — | EP | disclosed |
| US-12371547-B2 | Inorganic-reinforced thermoplastic polyester resin composition and molded products comprising same | TOYOBO MC CORPORATION (JP) | 2025-07-29 | — | — | US | disclosed |
| US-4322521-A | Process for producing halogenated aromatic polyesters | CELANESE CORPORATION (US) | 1982-03-30 | — | — | US | disclosed |
| US-4316981-A | Polycarbonate transesterification | GENERAL ELECTRIC COMPANY (US) | 1982-02-23 | — | — | US | disclosed |
| US-4102859-A | PHOSPHOROUS ACID ESTERS WITH OXETANE COMPOUNDS | BAYER AKTIENGESELLSCHAFT (DE) | 1978-07-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12617753-B2 | Urea derivatives and their use as curatives and curative accelerators for resin systems | UTS2R, UPP1, XDH | TSHR 3401/4885CYP3A4 3441/4885TDP1 807/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.